L3VLUP
ProSign in

NVST in the 13F filings

Envista Holdings Corporation · CUSIP 29415F104

Sector · Medical devices and instrumentsTheme · Healthcare: biopharma and medtech· L3VLUP-definedTheme · Surgical, medical and electromedical devices
Quarter
Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023
Quarter end
31 Dec 2024
the date the book describes
Filed
14 Feb 2025
latest of these filings; the earliest 12 Feb 2025
Managers listing it
4
at least, of 95 tracked, among listed positions
Comparable managers
94
filed both Q3 2024 and Q4 2024; 4 listed it in both
Shares listed
15,595,908
combined, among listed positions
Reported value
$301m
combined, at the quarter end

Among the 94 comparable managers: 2 buyers (opened or added shares) and 2 sellers (trimmed or exited), at least, among listed positions. Their net change in shares was -199,814.

Managers listing NVST in Q4 2024

Share of 13F value is the position’s reported value over everything the manager reported that quarter. The share change is against Q3 2024, and only where both filings list the position. A rise in value with no rise in shares is the price, not buying.

4 of 4 holders

ActionFiling
Harris Associates LP9,421,314$182m0.24%Trimmed-1,064,74014 Feb 2025 (the filing on sec.gov)
MFS Investment Management3,271,175$63munder 0.1%Added+283,41512 Feb 2025 (the filing on sec.gov)
Point72 Asset Management LP2,489,474$48m0.11%Added+588,72514 Feb 2025 (the filing on sec.gov)
Winton Group Ltd413,945$8.0m0.53%Trimmed-7,21412 Feb 2025 (the filing on sec.gov)

Largest increases and reductions, by shares

Q3 2024 to Q4 2024, among managers that listed it in both quarters or opened it.

Increases

Reductions

New positions and exits

At least these many: a manager is shown exiting only where its own filing shows the position gone.

New (0)

No new position among listed positions.

Exited (0)

No exit shown by a manager’s own filing.

Ownership over time

Every quarter on file. A quarter-end value moves with the price as well as with the shares held; buyers and sellers count comparable managers, by shares.
4 in Q3 2024 to 9 in Q2 2026

Tracked managers listing it, at least.

051015202020202120222023202420252026
the quarter shown share split complete books; unmarked quarters rest on listed positionsClick a quarter to open it.
NVST by quarter
QuarterHoldersReported valueBuyersSellers
Q3 20198$178mn.a.n.a.
Q4 201917$1.6bnn.a.n.a.
Q1 20206$541mn.a.n.a.
Q2 20208$911mn.a.n.a.
Q3 20209$873mn.a.n.a.
Q4 202011$1.4bnn.a.n.a.
Q1 202113$2.4bnn.a.n.a.
Q2 202116$2.1bnn.a.n.a.
Q3 20219$1.4bnn.a.n.a.
Q4 20217$1.6bnn.a.n.a.
Q1 202210$2.3bnn.a.n.a.
Q2 20229$1.8bnn.a.n.a.
Q3 202211$1.4bnn.a.n.a.
Q4 20229$812mn.a.n.a.
Q1 202311$1.2bnn.a.n.a.
Q2 202311$868mn.a.n.a.
Q3 20239$694mn.a.n.a.
Q4 202312$714m76
Q1 20249$393m47
Q2 20244$248m31
Q3 20244$312m13
Q4 20244$301m22
Q1 20254$263m31
Q2 20256$432m52
Q3 20255$359m32
Q4 20255$339m1913
Q1 20268$392m1817
Q2 20269$577m1914

Compare with…

Holders over time, buyers and sellers, and the managers holding both, side by side for up to four stocks.

NVST and LLY →NVST and JNJ →NVST and VRTX →Choose a stock to compare with NVST →

How much of the picture this is

A 13F is a manager’s long US-listed equity book at a quarter end, filed up to 45 days later. It shows no shorts, cash, bonds or performance, and it is never today’s portfolio. Large books are listed to their largest positions, so a manager missing from this table may still hold a small position below that line. These are 95 tracked managers, not the institutional market.

Which funds own NVST, latest filings →Back to the 13F Explorer →